{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T22:48:33Z","timestamp":1772750913684,"version":"3.50.1"},"reference-count":28,"publisher":"Japan Atherosclerosis Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT"],"published-print":{"date-parts":[[2010]]},"DOI":"10.5551\/jat.4663","type":"journal-article","created":{"date-parts":[[2011,6,16]],"date-time":"2011-06-16T13:45:38Z","timestamp":1308231938000},"page":"1132-1140","source":"Crossref","is-referenced-by-count":32,"title":["Long-Term Effects of Pioglitazone on Carotid Atherosclerosis in Japanese Patients with Type 2 Diabetes without a Recent History of Macrovascular Morbidity"],"prefix":"10.5551","volume":"17","author":[{"given":"Yoshimitsu","family":"Yamasaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Katakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigetaka","family":"Furukado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyuki","family":"Nagatsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsunori","family":"Kashiwagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Daida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuzo","family":"Kawamori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Kaku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199807233390404"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.16.2.434"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Laakso M: Glycemic control and the risk for coronary heart disease in patients with non-insulin-dependent dia-betes mellitus. The Finnish studies. Ann Intern Med, 1996; 124: 127-130","DOI":"10.7326\/0003-4819-124-1_Part_2-199601011-00009"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07037-8"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Bolen S, Feldman L, Vassy J, Wilson L, Yeh HC, Mari-nopoulos S, Wiley C, Selvin E, Wilson R, Bass EB, Bran-cati FL: Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes. Ann Int Med, 2007; 147: 386-399","DOI":"10.7326\/0003-4819-147-6-200709180-00178"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)90002-3"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000195790.24531.4f"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0190"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(99)00085-4"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.299.13.1561"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.21.joc60158"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67528-9"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.10.1180"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1185\/03007990903328124"},{"key":"16","unstructured":"16) Shima K, Endo J, Oimomi M, Oshima I, Omori Y, Kata-yama Y, Kanazawa Y, Kawai T, Kawamori R, Kanno T, Kiyose H, Kuwajima M, Nakashima K, Nagamine Y, Baba S, Hoshino T: Inter laboratory difference in GHb measurement in Japan-the fourth report of the GHb Standardization Committee, the Japan Diabetes Society, J Jpn Diab Soc, 1997; 40: 321-326 (in Japanese)"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.7.3452"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.5.1158"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr: Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Col-laborative Research Group. N Engl J Med, 1999; 340: 14-22","DOI":"10.1056\/NEJM199901073400103"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu CR, Liu CH, Azen SP: The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med, 1998; 128: 262-269","DOI":"10.7326\/0003-4819-128-4-199802150-00002"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000072273.67342.6D"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000236632.58323.cd"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Pfützner A, Marx N, Lubben G, Langenfeld M, Walcher D, Konrad T, Forst T: Improvement of cardiovascular risk markers by pioglitazone is independent from glycemic control: results from the pioneer study. J Am Coll Car-diol, 2005; 45: 1925-1931","DOI":"10.1016\/j.jacc.2005.03.041"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-004-1547-8"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Yamasaki Y, Katakami N, Hayaishi-Okano R, Matsuhisa M, Kajimoto Y, Kosugi K, Hatano M, Hori M: alpha-Glucosidase inhibitor reduces the progression of carotid intima-media thickness. Diabetes Res Crin Pract, 2005; 67: 204-210","DOI":"10.1016\/j.diabres.2004.07.012"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2008.12.006"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Campia U, Matuskey LA, Panza JA: Peroxisome prolifera-tor-activated receptor-gamma activation with pioglitazone improves endothelium-dependent dilation in nondiabetic patients with major cardiovascular risk factors. Circula-tion, 2006; 113: 867-875","DOI":"10.1161\/CIRCULATIONAHA.105.549618"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.5551\/jat.2527"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T18:44:56Z","timestamp":1621536296000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jat\/17\/11\/17_4663\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.4663","relation":{},"ISSN":["1880-3873","1340-3478"],"issn-type":[{"value":"1880-3873","type":"electronic"},{"value":"1340-3478","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}